glycine has been researched along with Cardiac Remodeling, Ventricular in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"We therefore hypothesised that the consequences of creatine-deficiency in mice would be impaired running capacity, and exacerbation of heart failure following myocardial infarction." | 7.79 | Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. ( Aksentijevic, D; Balaban, RS; Channon, KM; Clarke, K; Dawson, D; de Bono, JP; Hunyor, I; Lygate, CA; Medway, DJ; Neubauer, S; Phillips, D; Sebag-Montefiore, L; ten Hove, M; Watkins, H; Zervou, S, 2013) |
" These results suggest that sepiapterin prevents concentric LVH and dilatory remodeling after TAC primarily by increasing the bioavailability of NO." | 5.42 | Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats. ( Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K, 2015) |
"We therefore hypothesised that the consequences of creatine-deficiency in mice would be impaired running capacity, and exacerbation of heart failure following myocardial infarction." | 3.79 | Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice. ( Aksentijevic, D; Balaban, RS; Channon, KM; Clarke, K; Dawson, D; de Bono, JP; Hunyor, I; Lygate, CA; Medway, DJ; Neubauer, S; Phillips, D; Sebag-Montefiore, L; ten Hove, M; Watkins, H; Zervou, S, 2013) |
" These results suggest that sepiapterin prevents concentric LVH and dilatory remodeling after TAC primarily by increasing the bioavailability of NO." | 1.42 | Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats. ( Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
De Beer, D | 1 |
Mels, CM | 1 |
Schutte, AE | 1 |
Louw, R | 1 |
Delles, C | 1 |
Kruger, R | 1 |
Yoshioka, K | 1 |
Otani, H | 1 |
Shimazu, T | 1 |
Fujita, M | 1 |
Iwasaka, T | 1 |
Shiojima, I | 1 |
Bao, W | 1 |
Qin, P | 1 |
Needle, S | 1 |
Erickson-Miller, CL | 1 |
Duffy, KJ | 1 |
Ariazi, JL | 1 |
Zhao, S | 1 |
Olzinski, AR | 1 |
Behm, DJ | 1 |
Pipes, GC | 1 |
Jucker, BM | 1 |
Hu, E | 1 |
Lepore, JJ | 1 |
Willette, RN | 1 |
Lygate, CA | 1 |
Aksentijevic, D | 1 |
Dawson, D | 1 |
ten Hove, M | 1 |
Phillips, D | 1 |
de Bono, JP | 1 |
Medway, DJ | 1 |
Sebag-Montefiore, L | 1 |
Hunyor, I | 1 |
Channon, KM | 1 |
Clarke, K | 1 |
Zervou, S | 1 |
Watkins, H | 1 |
Balaban, RS | 1 |
Neubauer, S | 1 |
Lionetti, V | 1 |
Linke, A | 1 |
Chandler, MP | 1 |
Young, ME | 1 |
Penn, MS | 1 |
Gupte, S | 1 |
d'Agostino, C | 1 |
Hintze, TH | 1 |
Stanley, WC | 1 |
Recchia, FA | 1 |
5 other studies available for glycine and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Left ventricular mass and urinary metabolomics in young black and white adults: The African-PREDICT study.
Topics: Adult; Age Factors; Biomarkers; Black People; Echocardiography; Female; Glycine; Humans; Hydroxyprol | 2020 |
Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Topics: Animals; Aorta; Biopterins; Capillaries; Cell Size; Constriction; Dilatation, Pathologic; Enzyme Inh | 2015 |
Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
Topics: Animals; Cell Line; Coronary Vessels; Glycine; Hemodynamics; Hypoxia-Inducible Factor 1; Hypoxia-Ind | 2010 |
Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.
Topics: Adenylate Kinase; Animals; Creatine; Exercise Tolerance; Female; Glycine; Guanidinoacetate N-Methylt | 2013 |
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Carnitine O-Palmitoyltransferase; Dogs; Enzy | 2005 |